We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Symyx Metabolite Database Helps Accelerate R&D Productivity
Product News

Symyx Metabolite Database Helps Accelerate R&D Productivity

Symyx Metabolite Database Helps Accelerate R&D Productivity
Product News

Symyx Metabolite Database Helps Accelerate R&D Productivity


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Symyx Metabolite Database Helps Accelerate R&D Productivity"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Symyx Technologies, Inc. has announced that the latest release of the Symyx Metabolite database - the largest and most comprehensive collection of drug metabolism data in the world-is now available to pharmaceutical, agrochemical, and biotechnology researchers via the Symyx Isentris® data access, analysis, and decision support system, as well as the Web-based DiscoveryGate® content platform.

"Symyx Metabolite accelerates R&D productivity by making it possible for scientists to focus on the most therapeutically promising compounds-those with the right metabolic profile-early in the discovery process," said Trevor Heritage, president of Symyx Software.

"Using Symyx Metabolite's structure-searchable metabolic schemes, biotransformation explorer, and easy-to-use query and browse tools, scientists can quickly explore the fate of parent compounds, their metabolites, and properties by leveraging in-house and Symyx database information."

With Isentris, pharmacologists and medicinal chemists can now explore metabolic biotransformation pathways in ways previously not possible. Combining in-house and Symyx Metabolite data, scientists are free to navigate through possible biotransformation routes generated from known metabolites, intermediates, and their known transformations.

As biotransformation pathways are explored, Isentris also informs scientists if there are additional toxic, physicochemical, or biological properties known about the metabolites and their intermediates. Scientists can drill down to related molecule information to further explore and report on possible adverse effects or properties as a result of metabolism.

In a complimentary manner, as scientists browse in-house molecule information, they can launch the biotransformation explorer in Symyx Isentris to investigate metabolic pathways and gain further insight into compounds of interest and their metabolic fate.
Advertisement